Neuro-ophthalmology, like in any field of medicine, has many areas where controversy exists in diagnosis and treatment. This book provides a comprehensive overview on the clinical presentation, diagnosis, and management of neuro-ophthalmic disorders and specifically addresses areas of controversy. Each chapter opens with a case to illustrate a pertinent controversy and poses a clinical question. These controversies are then discussed by world leading experts to provide a balanced viewpoint. This book is essential reading for neuro-ophthalmologists, ophthalmologists, and neurologists.
Neuro-ophthalmology, like in any field of medicine, has many areas where controversy exists in diagnosis and treatment. This book provides a comprehensive overview on the clinical presentation, diagnosis, and management of neuro-ophthalmic disorders and specifically addresses areas of controversy. Each chapter opens with a case to illustrate a pertinent controversy and poses a clinical question. These controversies are then discussed by world leading experts to provide a balanced viewpoint. This book is essential reading for neuro-ophthalmologists, ophthalmologists, and neurologists.
1. Should a patient with unexplained isolated optic atrophy have neuroimaging and further laboratory evaluation? 2. Should a young patient with a new diagnosis of optic neuritis have testing and treatment for multiple sclerosis (MS)? 3. Should a patient with optic disc edema with macular star figure (neuroretinitis) have lab testing and treatment? 4. Should a vasculoplastic patient with non arteritic anterior ischemic optic neuropathy have any testing? 5. What is the treatment for giant cell arteritis? 6. Should I do a bilateral or unilateral temporal artery biopsy in suspected giant cell arteritis? 7. Should I treat traumatic optic neuropathy? 8. Should I do a MRI or MR venogram in every patient with pseudotumor cerebri? 9. Should we perform carotid Doppler and cardiac echo on young patients with transient visual loss? 10. What is the best visual field test for neuro-ophthalmology? 11. Does visual rehabilitation therapy (e.g. Novavision) help patients with homonymous hemianopsia 12. Should a patient with a pupil involved third nerve palsy have an angiogram is the MRA or CTA are negative? 13. Do erectile dysfunction agents cause anterior ischemic optic neuropathy? 14. Does amiodarone produce an optic neuropathy? 15. Should I start my patient with myasthenia gravis on steroids to reduce the chance of generalized myasthenia gravis? 16. Does radiation therapy work for thyroid ophthalmopathy? 17. Should I do topical pharmacologic testing in the Horner syndrome? 18. Should a patient with giant cell arteritis have a fluorescein angiogram? 19. Does pseudotumor cerebri without papilledema exist? 20. Does a patient with an isolated vasculopathic ocular motor cranial nerve palsy need a neuroimaging study?
1. Should a patient with unexplained isolated optic atrophy have neuroimaging and further laboratory evaluation? 2. Should a young patient with a new diagnosis of optic neuritis have testing and treatment for multiple sclerosis (MS)? 3. Should a patient with optic disc edema with macular star figure (neuroretinitis) have lab testing and treatment? 4. Should a vasculoplastic patient with non arteritic anterior ischemic optic neuropathy have any testing? 5. What is the treatment for giant cell arteritis? 6. Should I do a bilateral or unilateral temporal artery biopsy in suspected giant cell arteritis? 7. Should I treat traumatic optic neuropathy? 8. Should I do a MRI or MR venogram in every patient with pseudotumor cerebri? 9. Should we perform carotid Doppler and cardiac echo on young patients with transient visual loss? 10. What is the best visual field test for neuro-ophthalmology? 11. Does visual rehabilitation therapy (e.g. Novavision) help patients with homonymous hemianopsia 12. Should a patient with a pupil involved third nerve palsy have an angiogram is the MRA or CTA are negative? 13. Do erectile dysfunction agents cause anterior ischemic optic neuropathy? 14. Does amiodarone produce an optic neuropathy? 15. Should I start my patient with myasthenia gravis on steroids to reduce the chance of generalized myasthenia gravis? 16. Does radiation therapy work for thyroid ophthalmopathy? 17. Should I do topical pharmacologic testing in the Horner syndrome? 18. Should a patient with giant cell arteritis have a fluorescein angiogram? 19. Does pseudotumor cerebri without papilledema exist? 20. Does a patient with an isolated vasculopathic ocular motor cranial nerve palsy need a neuroimaging study?
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
